![](/img/cover-not-exists.png)
A phase II study of amrubicin and topotecan combination therapy in patients with relapsed or extensive-disease small-cell lung cancer: Okayama Lung Cancer Study Group Trial 0401
Nogami, Naoyuki, Hotta, Katsuyuki, Kuyama, Shoichi, Kiura, Katsuyuki, Takigawa, Nagio, Chikamori, Kenichi, Shibayama, Takuo, Kishino, Daizo, Hosokawa, Shinobu, Tamaoki, Akihiko, Harita, Shingo, TabataLanguage:
english
Journal:
Lung Cancer
DOI:
10.1016/j.lungcan.2011.01.018
Date:
February, 2011
File:
PDF, 220 KB
english, 2011